Novavax swings to profit in Q4 CEO remains optimistic despite U.S. regulatory uncertainties Shares surge over 22% after strong results Feb 26 (Reuters) - Novavax (NVAX.O), opens new tab raised its ...

Novavax reported fourth-quarter earnings of 11 cents, a shift from a loss of 51 cents a year ago. evenue for the fourth quarter was $147 million, a 67% year-over-year increase. Novavax on Thursday ...

A fear of needles can stop many children from getting a flu vaccine. But a new nasal spray will be available in 2026. Is your kid eligible?

Feb 26 (Reuters) - Novavax raised its adjusted revenue forecast for 2026 on Thursday, banking on milestone payments from licensing and supply deals for its shots, although it noted that the current ...

Experts say they are feeling "nervous" as Australia approached this year's flu season, with a new, fast-moving strain of influenza dubbed "Super-K" circulating as vaccine uptake dwindles.